Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...

The researchers completed a comprehensive functional assessment of all possible variants within the crucial DNA-binding domain of BRCA2, resulting in the clinical classification of 91% of variants ...

Scientists have analyzed thousands of mutations in the BRCA2 cancer gene, offering crucial insights. This research could help mitigate patient concerns or guide tailored treatments. By utilizing ...

One diagnosis of cancer in a family is heartbreaking, however it's another story for the Nolan sisters who have seen the ...

Get Instant Summarized Text (Gist) A comprehensive study has advanced the understanding of BRCA2 gene variants, crucial for assessing hereditary cancer risk. By functionally assessing nearly 7,000 ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...

Linda Nolan has become the third of the four Nolan sisters to have died from cancer disease in the past two years ...